Continue your support during #LiverCancerAwarenessMonth by getting back to the fundamentals of liver cancer. Explore this course of short video interviews covering hepatocellular carcinoma (HCC) topics. Register now: https://bit.ly/4g0zNyM
#embolization #radioembolization #immunotherapy #radiation
#embolization #radioembolization #immunotherapy #radiation
October 21, 2026 at 7:35 PM
Continue your support during #LiverCancerAwarenessMonth by getting back to the fundamentals of liver cancer. Explore this course of short video interviews covering hepatocellular carcinoma (HCC) topics. Register now: https://bit.ly/4g0zNyM
#embolization #radioembolization #immunotherapy #radiation
#embolization #radioembolization #immunotherapy #radiation
MEDICAL EVENT
Morgantown, WV, 10/05/2026
"On October 5, 2026, a patient undergoing Y-90 Therasphere radioembolization of the right medial tissue of the liver was underdosed by approximately 50 percent.
"The physician authorized user completed the administration as normal with no unusual circumsta…
Morgantown, WV, 10/05/2026
"On October 5, 2026, a patient undergoing Y-90 Therasphere radioembolization of the right medial tissue of the liver was underdosed by approximately 50 percent.
"The physician authorized user completed the administration as normal with no unusual circumsta…
Event Notifications
US Nuclear Regulatory Commission
www.nrc.gov
October 13, 2026 at 2:41 PM
MEDICAL EVENT
Morgantown, WV, 10/05/2026
"On October 5, 2026, a patient undergoing Y-90 Therasphere radioembolization of the right medial tissue of the liver was underdosed by approximately 50 percent.
"The physician authorized user completed the administration as normal with no unusual circumsta…
Morgantown, WV, 10/05/2026
"On October 5, 2026, a patient undergoing Y-90 Therasphere radioembolization of the right medial tissue of the liver was underdosed by approximately 50 percent.
"The physician authorized user completed the administration as normal with no unusual circumsta…
MEDICAL EVENT
Morgantown, WV, 10/05/2026
"On October 5, 2026, a patient undergoing Y-90 Therasphere radioembolization of the right medial tissue of the liver was underdosed by approximately 50 percent.
"The physician authorized user completed the administration as normal with no unusual […]
Morgantown, WV, 10/05/2026
"On October 5, 2026, a patient undergoing Y-90 Therasphere radioembolization of the right medial tissue of the liver was underdosed by approximately 50 percent.
"The physician authorized user completed the administration as normal with no unusual […]
Original post on mastodon.tds.xyz
mastodon.tds.xyz
October 13, 2026 at 2:41 PM
MEDICAL EVENT
Morgantown, WV, 10/05/2026
"On October 5, 2026, a patient undergoing Y-90 Therasphere radioembolization of the right medial tissue of the liver was underdosed by approximately 50 percent.
"The physician authorized user completed the administration as normal with no unusual […]
Morgantown, WV, 10/05/2026
"On October 5, 2026, a patient undergoing Y-90 Therasphere radioembolization of the right medial tissue of the liver was underdosed by approximately 50 percent.
"The physician authorized user completed the administration as normal with no unusual […]
MEDICAL EVENT
Oak Lawn, IL, 09/24/2026
"The licensee advised on September 24th, 2026, that a patient was to be administered 0.77 GBq of Y-90 Theraspheres during a planned left hepatic lobe radioembolization treatment. The licensee reported that during administration, the authorized user was […]
Oak Lawn, IL, 09/24/2026
"The licensee advised on September 24th, 2026, that a patient was to be administered 0.77 GBq of Y-90 Theraspheres during a planned left hepatic lobe radioembolization treatment. The licensee reported that during administration, the authorized user was […]
Original post on mastodon.tds.xyz
mastodon.tds.xyz
October 5, 2026 at 2:11 PM
MEDICAL EVENT
Oak Lawn, IL, 09/24/2026
"The licensee advised on September 24th, 2026, that a patient was to be administered 0.77 GBq of Y-90 Theraspheres during a planned left hepatic lobe radioembolization treatment. The licensee reported that during administration, the authorized user was […]
Oak Lawn, IL, 09/24/2026
"The licensee advised on September 24th, 2026, that a patient was to be administered 0.77 GBq of Y-90 Theraspheres during a planned left hepatic lobe radioembolization treatment. The licensee reported that during administration, the authorized user was […]
MEDICAL EVENT
Oak Lawn, IL, 09/24/2026
"The licensee advised on September 24th, 2026, that a patient was to be administered 0.77 GBq of Y-90 Theraspheres during a planned left hepatic lobe radioembolization treatment. The licensee reported that during administration, the authorized user was unable …
Oak Lawn, IL, 09/24/2026
"The licensee advised on September 24th, 2026, that a patient was to be administered 0.77 GBq of Y-90 Theraspheres during a planned left hepatic lobe radioembolization treatment. The licensee reported that during administration, the authorized user was unable …
Event Notifications
US Nuclear Regulatory Commission
www.nrc.gov
October 5, 2026 at 2:11 PM
MEDICAL EVENT
Oak Lawn, IL, 09/24/2026
"The licensee advised on September 24th, 2026, that a patient was to be administered 0.77 GBq of Y-90 Theraspheres during a planned left hepatic lobe radioembolization treatment. The licensee reported that during administration, the authorized user was unable …
Oak Lawn, IL, 09/24/2026
"The licensee advised on September 24th, 2026, that a patient was to be administered 0.77 GBq of Y-90 Theraspheres during a planned left hepatic lobe radioembolization treatment. The licensee reported that during administration, the authorized user was unable …
A Physics-Informed Neural Network Surrogate for Patient-Specific Hepatic Arterial Hemodynamics in Yttrium-90 Radioembolization: Network Architecture, Boundary-Condition Enforcement, and Data Efficiency https://www.biorxiv.org/content/10.64898/2026.09.26.754555v1
September 28, 2026 at 1:46 PM
A Physics-Informed Neural Network Surrogate for Patient-Specific Hepatic Arterial Hemodynamics in Yttrium-90 Radioembolization: Network Architecture, Boundary-Condition Enforcement, and Data Efficiency https://www.biorxiv.org/content/10.64898/2026.09.26.754555v1
A Physics-Informed Neural Network Surrogate for Patient-Specific Hepatic Arterial Hemodynamics in Yttrium-90 Radioembolization: Network Architecture, Boundary-Condition Enforcement, and Data Efficiency https://www.biorxiv.org/content/10.64898/2026.09.26.754555v1
September 28, 2026 at 1:46 PM
A Physics-Informed Neural Network Surrogate for Patient-Specific Hepatic Arterial Hemodynamics in Yttrium-90 Radioembolization: Network Architecture, Boundary-Condition Enforcement, and Data Efficiency https://www.biorxiv.org/content/10.64898/2026.09.26.754555v1
Just wanted to take a moment to reflect on how much it means to me to have received the 2026 Arthur M. Weis, PhD, Award in Radiation Dosimetry and Safety from the Education and Research Foundation (#ERF) for our work on post Y-90 radioembolization. Thanks to @snm-mi.bsky.social for the opportunity.
September 26, 2026 at 6:37 PM
Just wanted to take a moment to reflect on how much it means to me to have received the 2026 Arthur M. Weis, PhD, Award in Radiation Dosimetry and Safety from the Education and Research Foundation (#ERF) for our work on post Y-90 radioembolization. Thanks to @snm-mi.bsky.social for the opportunity.
5. A new review in 𝘙𝘢𝘥𝘪𝘰𝘭𝘰𝘨𝘺 from lead author Dr. Rony Avritscher discussing the integration of yttrium 90 (90Y) radioembolization with immunotherapy for advanced-stage hepatocellular carcinoma (HCC).
Dr. Avritscher is an ACS Research Scholar grantee.
doi.org/10.1148/radi...
Dr. Avritscher is an ACS Research Scholar grantee.
doi.org/10.1148/radi...
doi.org
September 25, 2026 at 10:43 PM
5. A new review in 𝘙𝘢𝘥𝘪𝘰𝘭𝘰𝘨𝘺 from lead author Dr. Rony Avritscher discussing the integration of yttrium 90 (90Y) radioembolization with immunotherapy for advanced-stage hepatocellular carcinoma (HCC).
Dr. Avritscher is an ACS Research Scholar grantee.
doi.org/10.1148/radi...
Dr. Avritscher is an ACS Research Scholar grantee.
doi.org/10.1148/radi...
Drs. Cheenu Kappadath and Armeen Mahvash have spent much of their careers researching how to help patients with hepatocellular carcinoma live longer — and they recently unlocked a new treatment.
More about this practice-changing work: spr.ly/6016B6n3Qi #OncSky #EndCancer
More about this practice-changing work: spr.ly/6016B6n3Qi #OncSky #EndCancer
Y90-radioembolization radiation therapy for liver cancer patients
Results of research from UT MD Anderson recently led to Food and Drug Administration (FDA) approval for the use of SIR-Spheres as a first-line treatment against unresectable and unablatable hepatocellular carcinoma tumors. But it took the right focus on collaboration and team science, coupled with resources, large patient volumes and unique expertise only available at UT MD Anderson for this to become a reality.
spr.ly
March 19, 2026 at 7:28 PM
Drs. Cheenu Kappadath and Armeen Mahvash have spent much of their careers researching how to help patients with hepatocellular carcinoma live longer — and they recently unlocked a new treatment.
More about this practice-changing work: spr.ly/6016B6n3Qi #OncSky #EndCancer
More about this practice-changing work: spr.ly/6016B6n3Qi #OncSky #EndCancer
@EASLnews An “aggressive” tumor board roster debating surgery, radioembolization and maybe even more for a BCLC C non cirrhotic patient with branch portal vein invasion! @bruixj @LorenzaRimassa @docamitgs @sapisochin #ILCA22
December 2, 2024 at 11:56 PM
@EASLnews An “aggressive” tumor board roster debating surgery, radioembolization and maybe even more for a BCLC C non cirrhotic patient with branch portal vein invasion! @bruixj @LorenzaRimassa @docamitgs @sapisochin #ILCA22
In less than 3 hours I must be to OSU main campus for Transarterial Radioembolization with Y-90 radiation. Dreading the day and ready to get it over with!
January 13, 2026 at 8:21 AM
In less than 3 hours I must be to OSU main campus for Transarterial Radioembolization with Y-90 radiation. Dreading the day and ready to get it over with!
“A comprehensive review on the current applications and future perspectives of radioembolization in endovascular neurosurgery” from Alex McClanahan, MD, MS.
jnis.bmj.com/content/earl...
jnis.bmj.com/content/earl...
March 21, 2026 at 4:22 PM
“A comprehensive review on the current applications and future perspectives of radioembolization in endovascular neurosurgery” from Alex McClanahan, MD, MS.
jnis.bmj.com/content/earl...
jnis.bmj.com/content/earl...
“Transarterial radioembolization generally results in low radiation exposure for medical staff”
“Interventional radiologists received highest body (mean, 2.5–4.5 µSv per procedure) & hand (mean, 146–309 µSv per procedure)”
pubs.rsna.org/doi/10.1148/...
“Interventional radiologists received highest body (mean, 2.5–4.5 µSv per procedure) & hand (mean, 146–309 µSv per procedure)”
pubs.rsna.org/doi/10.1148/...
March 21, 2026 at 11:50 AM
“Transarterial radioembolization generally results in low radiation exposure for medical staff”
“Interventional radiologists received highest body (mean, 2.5–4.5 µSv per procedure) & hand (mean, 146–309 µSv per procedure)”
pubs.rsna.org/doi/10.1148/...
“Interventional radiologists received highest body (mean, 2.5–4.5 µSv per procedure) & hand (mean, 146–309 µSv per procedure)”
pubs.rsna.org/doi/10.1148/...
“Arterial and portal phase enhancement differences on contrast-enhanced CT (CECT) correlate with lung shunt fraction from 99mTc-MAA imaging, supporting CECT’s potential as an alternative for pre-radioembolization lung dose estimation”
academic.oup.com/radadv/artic...
academic.oup.com/radadv/artic...
September 5, 2025 at 9:36 PM
“Arterial and portal phase enhancement differences on contrast-enhanced CT (CECT) correlate with lung shunt fraction from 99mTc-MAA imaging, supporting CECT’s potential as an alternative for pre-radioembolization lung dose estimation”
academic.oup.com/radadv/artic...
academic.oup.com/radadv/artic...
🔥 HOT TOPIC IN #HepatologyCommunications
New data highlight yttrium-90 (Y90) radioembolization, when guided by personalized dosimetry, as a leading option for unresectable BCLC A–B hepatocellular carcinoma.
📘https://bit.ly/4d1QjN9
New data highlight yttrium-90 (Y90) radioembolization, when guided by personalized dosimetry, as a leading option for unresectable BCLC A–B hepatocellular carcinoma.
📘https://bit.ly/4d1QjN9
May 14, 2026 at 2:00 PM
🔥 HOT TOPIC IN #HepatologyCommunications
New data highlight yttrium-90 (Y90) radioembolization, when guided by personalized dosimetry, as a leading option for unresectable BCLC A–B hepatocellular carcinoma.
📘https://bit.ly/4d1QjN9
New data highlight yttrium-90 (Y90) radioembolization, when guided by personalized dosimetry, as a leading option for unresectable BCLC A–B hepatocellular carcinoma.
📘https://bit.ly/4d1QjN9
NOTABLE ARTICLE, May 2026 #MedicalPhysics: Dosimetric impact of clinical planning methodology for Yttrium‐90 microsphere radioembolization
https://doi.org/10.1002/mp.70465
Please join us in congratulating Terrance Moretti et al, whose article was selected.
https://doi.org/10.1002/mp.70465
Please join us in congratulating Terrance Moretti et al, whose article was selected.
June 25, 2026 at 12:01 PM
NOTABLE ARTICLE, May 2026 #MedicalPhysics: Dosimetric impact of clinical planning methodology for Yttrium‐90 microsphere radioembolization
https://doi.org/10.1002/mp.70465
Please join us in congratulating Terrance Moretti et al, whose article was selected.
https://doi.org/10.1002/mp.70465
Please join us in congratulating Terrance Moretti et al, whose article was selected.
November 30, 2024 at 8:09 AM
Day 3 at #ECIO2026!
Highlights: lung & colorectal tumour boards, spinal mets, ECIO meets EUROSPINE & more.
🌟 Thierry de Baère Lecture by Afshin Gangi
Hands-on: ablation, confirmation software & radioembolization
💻 ecio2026.cirse.org/
Highlights: lung & colorectal tumour boards, spinal mets, ECIO meets EUROSPINE & more.
🌟 Thierry de Baère Lecture by Afshin Gangi
Hands-on: ablation, confirmation software & radioembolization
💻 ecio2026.cirse.org/
April 28, 2026 at 5:00 AM
Day 3 at #ECIO2026!
Highlights: lung & colorectal tumour boards, spinal mets, ECIO meets EUROSPINE & more.
🌟 Thierry de Baère Lecture by Afshin Gangi
Hands-on: ablation, confirmation software & radioembolization
💻 ecio2026.cirse.org/
Highlights: lung & colorectal tumour boards, spinal mets, ECIO meets EUROSPINE & more.
🌟 Thierry de Baère Lecture by Afshin Gangi
Hands-on: ablation, confirmation software & radioembolization
💻 ecio2026.cirse.org/
Free webinar: Eight years of real-world evidence on TARE
📌 TODAY! November 20, 2025, 17:00-18:15 CET
📄 Programme: t.ly/rmRJk
✔️ Access the webinar: t.ly/CitP8
#InterventionalRadiology #IRad #CIRSEwebinar #radioembolization
📌 TODAY! November 20, 2025, 17:00-18:15 CET
📄 Programme: t.ly/rmRJk
✔️ Access the webinar: t.ly/CitP8
#InterventionalRadiology #IRad #CIRSEwebinar #radioembolization
November 20, 2025 at 10:44 AM
Free webinar: Eight years of real-world evidence on TARE
📌 TODAY! November 20, 2025, 17:00-18:15 CET
📄 Programme: t.ly/rmRJk
✔️ Access the webinar: t.ly/CitP8
#InterventionalRadiology #IRad #CIRSEwebinar #radioembolization
📌 TODAY! November 20, 2025, 17:00-18:15 CET
📄 Programme: t.ly/rmRJk
✔️ Access the webinar: t.ly/CitP8
#InterventionalRadiology #IRad #CIRSEwebinar #radioembolization
Make sure to register for the upcoming webinar: Eight years of real-world evidence on TARE
📌 November 20, 2025, 17:00-18:15 CET
📄 Programme: t.ly/rmRJk
✔️ Registration: t.ly/CitP8
#InterventionalRadiology #IRad #CIRSEwebinar #radioembolization
📌 November 20, 2025, 17:00-18:15 CET
📄 Programme: t.ly/rmRJk
✔️ Registration: t.ly/CitP8
#InterventionalRadiology #IRad #CIRSEwebinar #radioembolization
November 6, 2025 at 6:25 AM
Make sure to register for the upcoming webinar: Eight years of real-world evidence on TARE
📌 November 20, 2025, 17:00-18:15 CET
📄 Programme: t.ly/rmRJk
✔️ Registration: t.ly/CitP8
#InterventionalRadiology #IRad #CIRSEwebinar #radioembolization
📌 November 20, 2025, 17:00-18:15 CET
📄 Programme: t.ly/rmRJk
✔️ Registration: t.ly/CitP8
#InterventionalRadiology #IRad #CIRSEwebinar #radioembolization
🎉Congrats to Prof. Riad Salem for winning this year’s Award of Excellence and Innovation in IR for his work on radioembolization as a treatment option for liver cancer which led to its incorporation into international guidelines.
👉 t.ly/4KZIg
👉 t.ly/4KZIg
August 19, 2025 at 10:47 AM
🎉Congrats to Prof. Riad Salem for winning this year’s Award of Excellence and Innovation in IR for his work on radioembolization as a treatment option for liver cancer which led to its incorporation into international guidelines.
👉 t.ly/4KZIg
👉 t.ly/4KZIg